Interested in Learning More about Infusion (IV) Therapy & Care

investor profile

April 27, 2021

by an investor from The Johns Hopkins University in Columbus, OH, USA

I'm surprised by the limited outpatient & ambulatory offerings of Infusion (IV) Therapies. Seems like this modality of treatment has grown meaningfully in the past few decades, across oncology, rheumatology, GI, neurology, et. al. - and even some treatments for COVID-19.

There's particularly limited access to ambulatory/outpatient (cheaper) offerings in rural areas. I grew up in Appalachia & serving rural communities is of great interest to me.
Would love to speak w/ anyone also interested in or knowledgable re: infusion therapy & the nuances around in-patient, ASC/outpatients, in-home infusion care & the current supply/demand dynamics in the U.S.

1
2
69
Replies
2
commentor profile
Reply by a searcher
from Northwestern University in Chicago, IL, USA
Cameron, I am researching this space now as a new revenue segment for a business I work with. Would be interested in comparing notes with you. vshevly [@] chcapital.com
commentor profile
Reply by a searcher
from Duke University in Marina Del Rey, CA 90292, USA
Hey Cameron - very interested here too. Did this search go anywhere for you?
Join the discussion